Tri Locum Partners LP Quant / Systematic

CIK: 0001826434 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $254,009 (100.0% shares, 0.0% debt)

Holdings (41)

ABBV ABBVIE INC 9.6%
Value ($000) $24,365 Shares 179,950 Est. Cost $101.71 Unrealized 0.0%
LLY LILLY ELI & CO 8.5%
Value ($000) $21,691 Shares 78,528 Est. Cost $243.85 Unrealized 0.0%
EW EDWARDS LIFESCIENCES CORP 7.5%
Value ($000) $19,095 Shares 147,396 Est. Cost $108.05 Unrealized +8.0%
ARGX ARGENX SE 6.7%
Value ($000) $16,931 Shares 48,347 Est. Cost $350.20 Unrealized
CHEMOCENTRYX INC 6.3%
Value ($000) $15,886 Shares 436,300 Est. Cost $35.70 Unrealized
APLS APELLIS PHARMACEUTICALS INC 5.9%
Value ($000) $15,048 Shares 318,269 Est. Cost $39.37 Unrealized 0.0%
KEZAR LIFE SCIENCES INC 4.8%
Value ($000) $12,248 Shares 732,515 Est. Cost $16.72 Unrealized
SKIN THE BEAUTY HEALTH COMPANY 4.8%
Value ($000) $12,232 Shares 506,280 Est. Cost $21.99 Unrealized +17.2%
PTGX PROTAGONIST THERAPEUTICS INC 4.2%
Value ($000) $10,736 Shares 313,929 Est. Cost $31.61 Unrealized 0.0%
ADICET BIO INC 4.0%
Value ($000) $10,204 Shares 583,402 Est. Cost $17.49 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 3.9%
Value ($000) $9,919 Shares 45,904 Est. Cost $196.78 Unrealized -0.2%
INHIBRX INC 3.7%
Value ($000) $9,309 Shares 213,174 Est. Cost $43.67 Unrealized
SEAGEN INC 3.6%
Value ($000) $9,267 Shares 59,940 Est. Cost $169.80 Unrealized
FATE FATE THERAPEUTICS INC 3.3%
Value ($000) $8,310 Shares 142,032 Est. Cost $56.68 Unrealized 0.0%
BELLUS HEALTH INC NEW 3.1%
Value ($000) $7,856 Shares 975,933 Est. Cost $5.25 Unrealized
EVH EVOLENT HEALTH INC 2.5%
Value ($000) $6,228 Shares 225,097 Est. Cost $28.69 Unrealized 0.0%
STVN STEVANATO GROUP S P A 2.0%
Value ($000) $5,089 Shares 226,700 Est. Cost $23.45 Unrealized 0.0%
LEGN LEGEND BIOTECH CORP 1.6%
Value ($000) $4,187 Shares 89,840 Est. Cost $50.56 Unrealized
X4 PHARMACEUTICALS INC 1.4%
Value ($000) $3,616 Shares 1,578,947 Est. Cost $2.29 Unrealized
SCIENCE 37 HOLDINGS INC 1.3%
Value ($000) $3,381 Shares 271,159 Est. Cost $12.47 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 1.3%
Value ($000) $3,355 Shares 24,346 Est. Cost $137.80 Unrealized
CATALENT INC 1.2%
Value ($000) $3,034 Shares 23,700 Est. Cost $128.02 Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 0.8%
Value ($000) $1,987 Shares 23,632 Est. Cost $77.38 Unrealized 0.0%
ABIOMED INC 0.7%
Value ($000) $1,857 Shares 5,169 Est. Cost $359.26 Unrealized
SKIN THE BEAUTY HEALTH COMPANY 0.7%
Value ($000) $1,788 Shares 74,000 Est. Cost $21.99 Unrealized +17.2%
RAPT THERAPEUTICS INC 0.7%
Value ($000) $1,768 Shares 48,141 Est. Cost $36.73 Unrealized
TRICIDA INC 0.6%
Value ($000) $1,623 Shares 169,786 Est. Cost $9.56 Unrealized
CYTK CYTOKINETICS INC 0.6%
Value ($000) $1,521 Shares 33,379 Est. Cost $38.59 Unrealized 0.0%
NVAX NOVAVAX INC 0.6%
Value ($000) $1,517 Shares 10,600 Est. Cost Unrealized
1LIFE HEALTHCARE INC 0.6%
Value ($000) $1,489 Shares 84,748 Est. Cost $17.57 Unrealized
INTRA-CELLULAR THERAPIES INC 0.5%
Value ($000) $1,370 Shares 26,177 Est. Cost $52.34 Unrealized
AMERICAN WELL CORP 0.5%
Value ($000) $1,358 Shares 224,876 Est. Cost $6.04 Unrealized
CANO HEALTH INC 0.5%
Value ($000) $1,261 Shares 141,508 Est. Cost $8.91 Unrealized
VIR VIR BIOTECHNOLOGY INC 0.5%
Value ($000) $1,256 Shares 30,000 Est. Cost Unrealized
SRRK SCHOLAR ROCK HLDG CORP 0.4%
Value ($000) $1,008 Shares 40,571 Est. Cost $27.60 Unrealized 0.0%
ACRS ACLARIS THERAPEUTICS INC 0.3%
Value ($000) $806 Shares 55,433 Est. Cost $15.15 Unrealized 0.0%
XENE XENON PHARMACEUTICALS INC 0.3%
Value ($000) $782 Shares 25,043 Est. Cost $17.38 Unrealized +72.0%
FEMY FEMASYS INC 0.2%
Value ($000) $568 Shares 145,631 Est. Cost $9.55 Unrealized -39.0%
DURECT CORP 0.0%
Value ($000) $26 Shares 26,387 Est. Cost $0.99 Unrealized
ASPIRA WOMENS HEALTH INC 0.0%
Value ($000) $19 Shares 10,876 Est. Cost $1.75 Unrealized
ATHERSYS INC NEW 0.0%
Value ($000) $18 Shares 19,449 Est. Cost $0.93 Unrealized